Armata Pharmaceuticals (ARMP)

• Market cap: $167M
• 1 day: -5.02%
• 5 days: -2.58%
• 1 month: -29.94%
• 3 months: -54.51%
• 6 months: -41.34%
• Year to date: -30.79%
• 1 year: 85.31%
• 5 years: 18.85%
• 10 years: -97.54%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Employees: 61